HCP Antibody Bias in Coverage Analysis You Didn’t Expect: What You Need to Fix Today
So, you’ve been tasked with analyzing host cell protein (HCP) coverage in your biotherapeutic process—and everything looks good on the surface. The ELISA you’re running shows strong signals, and your coverage analysis passes regulatory checkpoints. But here’s the thing no one tells you: the bias built into your anti-HCP antibodies could be skewing everything you…